These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33469076)

  • 1. Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy.
    Sonnenschein K; Fiedler J; de Gonzalo-Calvo D; Xiao K; Pfanne A; Just A; Zwadlo C; Soltani S; Bavendiek U; Kraft T; Dos Remedios C; Cebotari S; Bauersachs J; Thum T
    Sci Rep; 2021 Jan; 11(1):1755. PubMed ID: 33469076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy.
    Sonnenschein K; Wilczek AL; de Gonzalo-Calvo D; Pfanne A; Derda AA; Zwadlo C; Bavendiek U; Bauersachs J; Fiedler J; Thum T
    Sci Rep; 2019 Dec; 9(1):20350. PubMed ID: 31889077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy.
    Thottakara T; Lund N; Krämer E; Kirchhof P; Carrier L; Patten M
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.
    Hasegawa K; Fujiwara H; Doyama K; Miyamae M; Fujiwara T; Suga S; Mukoyama M; Nakao K; Imura H; Sasayama S
    Circulation; 1993 Aug; 88(2):372-80. PubMed ID: 8339400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.
    Derda AA; Thum S; Lorenzen JM; Bavendiek U; Heineke J; Keyser B; Stuhrmann M; Givens RC; Kennel PJ; Schulze PC; Widder JD; Bauersachs J; Thum T
    Int J Cardiol; 2015 Oct; 196():115-22. PubMed ID: 26086795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Obstructive Hypertrophic Cardiomyopathy from Nonobstructive Hypertrophic Cardiomyopathy: Development and Validation of a Model Based on Electrocardiogram Features.
    Guo L; Ma Z; Yang W; Zhang F; Shao H; Liu L; Gao C; Tao L
    Glob Heart; 2023; 18(1):40. PubMed ID: 37547171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy.
    Sahin I; Gungor B; Ozkaynak B; Uzun F; Küçük SH; Avci II; Ozal E; Ayça B; Cetın S; Okuyan E; Dinckal MH
    Clin Cardiol; 2017 Jan; 40(1):32-37. PubMed ID: 27768229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial long noncoding RNAs as blood based biomarkers for cardiac remodeling in patients with hypertrophic cardiomyopathy.
    Kitow J; Derda AA; Beermann J; Kumarswarmy R; Pfanne A; Fendrich J; Lorenzen JM; Xiao K; Bavendiek U; Bauersachs J; Thum T
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H707-12. PubMed ID: 27422984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) study.
    Zhu A; Bews H; Cheung D; Nagalingam RS; Mittal I; Goyal V; Asselin CY; Kirkpatrick IDC; Czubryt MP; Jassal DS
    Can J Physiol Pharmacol; 2020 Jul; 98(7):459-465. PubMed ID: 32027517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological characteristics of hypertrophic cardiomyopathy estimated by left ventriculography.
    Ohtani T; Hamada M; Hiwada K
    Jpn Circ J; 1993 May; 57(5):418-25. PubMed ID: 8510312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulsed Doppler echocardiographic assessment of diastolic left ventricular hemodynamics in hypertrophic cardiomyopathy: relationship between the mode of left ventricular filling and the distribution of left ventricular hypertrophy].
    Oki T; Asai M; Takemura H; Fukuda N; Sakai H; Tominaga T; Murao A; Ohshima C; Kusaka Y; Niki T
    J Cardiogr; 1983 Sep; 13(3):523-35. PubMed ID: 6687193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of left ventricular diastolic function by global strain rate imaging in patients with obstructive hypertrophic cardiomyopathy: a simultaneous speckle tracking echocardiography and cardiac catheterization study.
    Chen S; Yuan J; Qiao S; Duan F; Zhang J; Wang H
    Echocardiography; 2014 May; 31(5):615-22. PubMed ID: 24219240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac magnetic field map topology quantified by Kullback-Leibler entropy identifies patients with hypertrophic cardiomyopathy.
    Schirdewan A; Gapelyuk A; Fischer R; Koch L; Schütt H; Zacharzowsky U; Dietz R; Thierfelder L; Wessel N
    Chaos; 2007 Mar; 17(1):015118. PubMed ID: 17411275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy.
    Captur G; Doykov I; Chung SC; Field E; Barnes A; Zhang E; Heenan I; Norrish G; Moon JC; Elliott PM; Heywood WE; Mills K; Kaski JP
    Circ Genom Precis Med; 2024 Jun; 17(3):e004448. PubMed ID: 38847081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences at the Time of Myectomy in Hypertrophic Cardiomyopathy.
    Nijenkamp LLAM; Bollen IAE; van Velzen HG; Regan JA; van Slegtenhorst M; Niessen HWM; Schinkel AFL; Krüger M; Poggesi C; Ho CY; Kuster DWD; Michels M; van der Velden J
    Circ Heart Fail; 2018 Jun; 11(6):e004133. PubMed ID: 29853478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mode of splitting of the second heart sound in patients with hypertrophic cardiomyopathy].
    Fukuda N; Oki T; Sakai H; Asai M; Ohshima C; Kusaka Y; Tominaga T; Murao A; Niki T; Mori H
    J Cardiogr; 1983 Jun; 13(2):327-41. PubMed ID: 6687124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac magnetic resonance T2 mapping and feature tracking in athlete's heart and HCM.
    Gastl M; Lachmann V; Christidi A; Janzarik N; Veulemans V; Haberkorn S; Holzbach L; Jacoby C; Schnackenburg B; Berrisch-Rahmel S; Zeus T; Kelm M; Bönner F
    Eur Radiol; 2021 May; 31(5):2768-2777. PubMed ID: 33063183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.